ARLZ
Aralez Pharmaceuticals Inc.
ARLZ
ARLZ
Delisted
ARLZ was delisted on the 20th of August, 2018.
59 hedge funds and large institutions have $29.6M invested in Aralez Pharmaceuticals Inc. in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 15 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
63% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 16
Holders
59
Holding in Top 10
–
Calls
$386K
Puts
$320K
Top Buyers
| 1 | +$394K | |
| 2 | +$260K | |
| 3 | +$114K | |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$88K |
| 5 |
VF
Virtu Financial
New York
|
+$67K |
Top Sellers
| 1 | -$2.75M | |
| 2 | -$360K | |
| 3 | -$270K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$247K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$176K |